Medical Equipment Financing Market (By Equipment: Diagnostics Equipment, Therapeutic Equipment, Patient Monitoring Equipment, Laboratory Equipment, Medical Furniture; By Type: New Medical Equipment, Rental Equipment, Refurbished Equipment; By End User: Hospitals, Clinics, Laboratories & Diagnostic Centers, Laboratories & Diagnostic Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global medical equipment financing market size was USD 173.04 billion in 2023, accounted for USD 186.02 billion in 2024, and is expected to reach around USD 356.65 billion by 2033, expanding at a CAGR of 7.5% from 2024 to 2033.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. medical equipment financing market size was estimated at USD 34.79 billion in 2023 and is predicted to be worth around USD 76.50 billion by 2033, at a CAGR of 8.2% from 2024 to 2033.
The market for financing medical equipment in North America has grown to be the largest and was USD 49.60 billion in 2023. The highest financing rate for medical equipment in the area is the main cause of this dominance. The domination of this region has been aided by ongoing medical device advances and expenditures in the medical infrastructure. Additionally, due to the increasing adoption of artificial intelligence technology-based medical equipment finance and expanding expenditures in healthcare infrastructure, Europe has the second position in the industry. In addition, greater knowledge of the finance sector among medical professionals and staff has drawn more clients to the market for equipment financing. Additionally, the industry is anticipated to rise during the forecast period amid a number of Eastern European countries experiencing a solid economy
In contrast, Asia Pacific is anticipated to grow more quickly due to the expansion of the finance sector in the region and the construction of hospitals, cutting-edge laboratories, and diagnostic centers in its developing nations. Government funding commitments to the medical sector would also aid in the expansion of this market. For instance, the Indian finance minister recently announced a $ 9.09 billion commitment to the healthcare sector as part of the country's 2020 budget. The establishment of more hospitals across the nation was the primary goal of the funding. The market size is projected to grow during the forecast period as a result of such investments. In addition, the markets in Latin America, the Middle East, and Africa are expected to expand significantly because fewer people are aware of the financial rules and structures and have poor comprehension of them.
The healthcare financing sector was significantly impacted by COVID-19. During the pandemic, managing the influx of patients was one of the hospitals' initial challenges. There was a lack of beds and ventilators, ambulances were in such great demand that non-ambulance vehicles were outfitted with equipment to provide patient transport, and there was a scarcity of personal protective equipment (PPE). Elective and non-emergency operations were stopped. Examinations for dental, optical, and wellness were rescheduled. Staffing and income were harmed by the loss of routine care. Healthcare companies hurried to create COVID-19 test kits, while pharmaceutical companies switched gears to start working on vaccine development as soon as it was practical. There was a considerable shift in the demand for equipment, according to an August 2020 report titled "COVID-19 and Its Impact on Healthcare Financing." The budgets and equipment needs of DLL's clients, a global asset finance partner, are always shifting. Flexible financing alternatives have been able to quickly deploy critical assets and prepare for an influx of future processes when the economy recovers while minimizing upfront financial limits in response to changing needs. Therefore, such scenarios that produce diverse & adaptable financing solutions are projected to fuel market expansion during the predicted period.
The demand for top-notch healthcare and related services is growing dramatically as incomes rise. Furthermore, being able to provide the most recent medical standards and practices has turned into a must for doctors rather than differentiation. However, upgrading facilities or spending money on state-of-the-art medical technology is not an easy task. This includes significant expenses that are almost unaffordable for the majority of small healthcare service providers. Using available funds to pay for medical equipment could limit working capital and restrict the cash flow required for regular business operations. Therefore, the most economical approach to guarantee that patients have access to the greatest medical care without going bankrupt is to take out a medical equipment loan.
Technological developments in the market and rising patient demand are further factors promoting market progress. The healthcare industry, like any other, needs technology to serve the evolving needs of patients. The technical infrastructure is a key factor in determining the quality of patient care, from computerized medical records to cutting-edge diagnostic tools. The need for cutting-edge equipment has increased dramatically as hospitals, clinics, and other healthcare facilities struggle to gain a competitive edge. The aging population and increased access to healthcare in small towns and rural areas have increased the demand for sophisticated technologies. As a result, this will probably increase demand for medical equipment financing and propel industry expansion.
Report Coverage | Details |
Market Size in 2023 | USD 173.04 Billion |
Market Size in 2024 | USD 186.02 Billion |
Market Size by 2033 | USD 356.65 Billion |
Growth Rate from 2024 to 2033 | CAGR of 7.5% |
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | By Equipment, By Type, and By End User |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Rising preference for same-day surgery
Businesses' prudent capital expenditure
Technological innovation
In 2023, the market for diagnostic equipment was estimated to be worth USD 48.3 billion. Due to better healthcare infrastructure and a booming healthcare industry, there is a greater need for premium, high-quality, and cutting-edge healthcare facilities in developing countries. Due to the increased demand for technologically enhanced medical care, new and inventive items for providing these treatments, as well as related services, have been developed all of which are relatively expensive to purchase. There is a growing tendency towards the establishment of more diagnostic centers as a result of the rising prevalence of infectious diseases and advancements in diagnostic technology. This, in turn, is to blame for increased funding for diagnostic equipment. Additionally, end users frequently invest in cutting-edge diagnostic and therapeutic equipment, such as dialysis machines, ventilators, and ICU equipment, in order to give the patient the best possible medical treatment. For example, the COVID crisis in 2019 has increased demand for ventilators as well as other diagnostic tools like X-ray scanners and MRI scans. In the upcoming months, this is projected to raise the market value of both the therapeutic and diagnostic sectors. Additionally, hospitals have increased their facility investment due to patient demand for intensive care unit capabilities. Every end user now depends on patient monitoring technology including Electrocardiograph (ECG) monitors, incubators, and EHR systems.
Customers consequently opt to use financing services to buy these diagnostic tools, driving statistics for the diagnostic equipment finance sector category.
In 2023, the market for reconditioned goods was maximum. Medical equipment that has undergone reconditioning or restoration to a workable state without altering its primary purpose or original specifications is referred to as refurbished equipment. Only after complete cleaning, disinfection, and replacement of any worn or broken parts is this equipment utilized. Due to financial constraints, the demand for reconditioned medical equipment is particularly significant in emerging nations.
New medical equipment costs between 30 and 50 percent more than refurbished equipment. Additionally, a number of e-commerce sites are predicted to offer simple ways to buy and sell reconditioned medical equipment. These advantages of used equipment will fuel market expansion on both a segmental and global level.
Creation of diagnostic tools to support the expansion of diagnostic centers and labs. The hospital and clinic industry kept the top spot in the market in 2023. This dominance is attributable to elements like increased investment in infrastructure management and rising demand from patients at clinics and hospitals for surgical operations. Due to the availability of an established medical infrastructure and increased patient preference, hospitals and clinics are seeing tremendous expansion. Due to the quick availability of sufficient finances from finance businesses, hospitals and clinics quickly adapt and install newly introduced medical technologies. The need for therapeutic equipment is also being facilitated by an increase in patient admissions owing to infectious diseases like COVID-19, respiratory problems, cardiology disorders, and others, which is opening up a variety of chances for financial businesses.
The development of diagnostic kits and suitable equipment for patient healthcare, on the other hand, is predicted to lead to a faster increase in the laboratories and diagnostic centers segment over the course of the projection year. For instance, there has been a significant need for diagnostic kits in both diagnostic centers and cutting-edge laboratories due to the present global pandemic emergency of COVID-19. Equipment finance firms are making progress in providing funding for research and development to reduce the danger of pandemics around the world.
Recent Developments
Segment Covered in the Report
By Equipment
By Type
By End User
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Equipment Financing Market
5.1. COVID-19 Landscape: Medical Equipment Financing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Equipment Financing Market, By Equipment
8.1. Medical Equipment Financing Market, by Equipment, 2024-2033
8.1.1 Diagnostics Equipment
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Therapeutic Equipment
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Patient Monitoring Equipment
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Laboratory Equipment
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Medical Furniture
8.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Medical Equipment Financing Market, By Type
9.1. Medical Equipment Financing Market, by Type, 2024-2033
9.1.1. New Medical Equipment
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Rental Equipment
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Refurbished Equipment
9.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Medical Equipment Financing Market, By End User
10.1. Medical Equipment Financing Market, by End User, 2024-2033
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Clinics
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Laboratories & Diagnostic Centers
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Ambulatory Surgical Centers
10.1.4.1. Market Revenue and Forecast (2021-2033)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Medical Equipment Financing Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.1.2. Market Revenue and Forecast, by Type (2021-2033)
11.1.3. Market Revenue and Forecast, by End User (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.1.4.2. Market Revenue and Forecast, by Type (2021-2033)
11.1.4.3. Market Revenue and Forecast, by End User (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.1.5.2. Market Revenue and Forecast, by Type (2021-2033)
11.1.5.3. Market Revenue and Forecast, by End User (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.2.2. Market Revenue and Forecast, by Type (2021-2033)
11.2.3. Market Revenue and Forecast, by End User (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.2.4.2. Market Revenue and Forecast, by Type (2021-2033)
11.2.4.3. Market Revenue and Forecast, by End User (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.2.5.2. Market Revenue and Forecast, by Type (2021-2033)
11.2.5.3. Market Revenue and Forecast, by End User (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.2.6.2. Market Revenue and Forecast, by Type (2021-2033)
11.2.6.3. Market Revenue and Forecast, by End User (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.2.7.2. Market Revenue and Forecast, by Type (2021-2033)
11.2.7.3. Market Revenue and Forecast, by End User (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.3.2. Market Revenue and Forecast, by Type (2021-2033)
11.3.3. Market Revenue and Forecast, by End User (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.3.4.2. Market Revenue and Forecast, by Type (2021-2033)
11.3.4.3. Market Revenue and Forecast, by End User (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.3.5.2. Market Revenue and Forecast, by Type (2021-2033)
11.3.5.3. Market Revenue and Forecast, by End User (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.3.6.2. Market Revenue and Forecast, by Type (2021-2033)
11.3.6.3. Market Revenue and Forecast, by End User (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.3.7.2. Market Revenue and Forecast, by Type (2021-2033)
11.3.7.3. Market Revenue and Forecast, by End User (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.4.2. Market Revenue and Forecast, by Type (2021-2033)
11.4.3. Market Revenue and Forecast, by End User (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.4.4.2. Market Revenue and Forecast, by Type (2021-2033)
11.4.4.3. Market Revenue and Forecast, by End User (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.4.5.2. Market Revenue and Forecast, by Type (2021-2033)
11.4.5.3. Market Revenue and Forecast, by End User (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.4.6.2. Market Revenue and Forecast, by Type (2021-2033)
11.4.6.3. Market Revenue and Forecast, by End User (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.4.7.2. Market Revenue and Forecast, by Type (2021-2033)
11.4.7.3. Market Revenue and Forecast, by End User (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.5.2. Market Revenue and Forecast, by Type (2021-2033)
11.5.3. Market Revenue and Forecast, by End User (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.5.4.2. Market Revenue and Forecast, by Type (2021-2033)
11.5.4.3. Market Revenue and Forecast, by End User (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Equipment (2021-2033)
11.5.5.2. Market Revenue and Forecast, by Type (2021-2033)
11.5.5.3. Market Revenue and Forecast, by End User (2021-2033)
Chapter 12. Company Profiles
12.1. Hero FinCorp
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. National Funding
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Blue Bridge Financial, LLC
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. First American Equipment Finance
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. SMC Finance
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Siemens Financial Services, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. SLR Healthcare ABL
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. TIAA Bank
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. JPMorgan Chase & Co.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Macquarie Group Limited
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client